Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study

Background: Anticoagulation therapy following cerebral vein thrombosis (CVT) can improve mortality and morbidity. Vitamin K antagonists are currently the routine oral anticoagulant used for CVT; while by introduction of rivaroxaban, a direct factor Xa inhibitor, the attentions have been deviated tow...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorvash, Fariborz, Farajpour-Khanaposhtani, Mohammad Javad, Hemasian, Helia, Saadatnia, Sayed Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984779/
http://dx.doi.org/10.18502/cjn.v20i3.7687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984779/
http://dx.doi.org/10.18502/cjn.v20i3.7687

Ejemplares similares